Literature DB >> 32421874

Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts.

Willy Albert Flegel1, Franz Friedrich Wagner2, Diarmaid Padraig Ó Donghaile3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32421874      PMCID: PMC9067349          DOI: 10.1111/trf.15788

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  10 in total

Review 1.  Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.

Authors:  Adair Seager; S G Sandler
Journal:  Immunohematology       Date:  2013

2.  Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions.

Authors:  Komal Arora; James Kelley; Dawen Sui; Jing Ning; Fernando Martinez; Benjamin Lichtiger; Ashok Tholpady
Journal:  Transfusion       Date:  2017-02-12       Impact factor: 3.157

Review 3.  Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.

Authors:  Joan Cid; Miguel Lozano; Harvey G Klein; Willy A Flegel
Journal:  Blood Transfus       Date:  2014-03-19       Impact factor: 3.443

4.  It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies.

Authors:  Mark H Yazer; Meghan Delaney; Heidi Doughty; Nancy M Dunbar; Arwa Z Al-Riyami; Darrell J Triulzi; Jon F Watchko; Erica M Wood; Vered Yahalom; Stephen P Emery
Journal:  Transfusion       Date:  2019-10-18       Impact factor: 3.157

5.  A case for stocking O D+ red blood cells in emergency room trauma bays.

Authors:  Erin Meyer; Lynne Uhl
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

6.  Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study.

Authors:  Kathleen Selleng; Gregor Jenichen; Kathrin Denker; Sixten Selleng; Bernd Müllejans; Andreas Greinacher
Journal:  Lancet Haematol       Date:  2017-04-04       Impact factor: 18.959

7.  Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery.

Authors:  G Ramsey; L F Hahn; F W Cornell; D J Boczkowski; S Staschak; R Clark; R L Hardesty; B P Griffith; T E Starzl
Journal:  Transplantation       Date:  1989-06       Impact factor: 4.939

8.  Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.

Authors:  Joan Cid; Miguel Lozano; Alyssa Ziman; Kamille A West; Kerry L O'Brien; Michael F Murphy; Silvano Wendel; Alejandro Vázquez; Xavier Ortín; Tor A Hervig; Meghan Delaney; Willy A Flegel; Mark H Yazer
Journal:  Br J Haematol       Date:  2014-10-04       Impact factor: 6.998

9.  O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study.

Authors:  Nancy M Dunbar; Mark H Yazer
Journal:  Transfusion       Date:  2018-02-25       Impact factor: 3.157

10.  Unmatched Type O RhD+ Red Blood Cells in Multiple Injured Patients.

Authors:  Sabine Flommersfeld; Carsten Mand; Christian A Kühne; Gregor Bein; Steffen Ruchholtz; Ulrich J Sachs
Journal:  Transfus Med Hemother       Date:  2018-03-07       Impact factor: 3.747

  10 in total
  5 in total

1.  Proceed with care: the "uncommon" serologic weak D phenotypes.

Authors:  Willy Albert Flegel
Journal:  Blood Transfus       Date:  2021-07       Impact factor: 3.443

2.  Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans.

Authors:  K Srivastava; M U Bueno; W A Flegel
Journal:  Immunohematology       Date:  2022-04-29

3.  Modern Rhesus (Rh) typing in transfusion and pregnancy.

Authors:  Willy Albert Flegel
Journal:  CMAJ       Date:  2021-01-25       Impact factor: 8.262

4. 

Authors:  Willy Albert Flegel
Journal:  CMAJ       Date:  2021-03-29       Impact factor: 8.262

Review 5.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.